Correlation of Calpain Sensitivity, Bradford Assay Instability, and Electrophoretic Mobility in Phosphomimetic Mutants of GlyT2 N-terminus

Overview

Journal Biochem Biophys Rep

Specialty Biochemistry

Date 2024 May 27

PMID 38799113

Authors

Martina Baliova

Frantisek Jursky

Affiliations

Soon will be listed here.

Abstract

The glycine transporter GlyT2 plays an important role in glycine-inhibitory neurotransmission of the hindbrain and spinal cord. Its special feature is the extended N-terminus, which contains a large number of potentially phosphorylated serine and threonine residues. Due to its unstructured nature, it is difficult to address the changes introduced by potential phosphorylation. Here, we used relatively simple methods such as calpain sensitivity, Bradford instability, and SDS electrophoretic mobility shift to investigate the effect of multiple phosphomimetic mutations versus neutral mutations on GlyT2N properties. The replacement of several serines or threonines with neutral alanines did not have a significant effect on the studied GlyT2N properties. Replacement of the same residues with phosphomimetic aspartate resulted in significant alterations in calpain cleavage patterns, Bradford instability, and SDS gel protein mobility. Interestingly, a correlation between the relative intensity of the measured effects was observed, indicating that they all reflect similar structural changes introduced by potential phosphorylation Results indicate that a potential single or multiple phosphorylation significantly alters the proteomic properties of the glycine transporter GlyT2 N-terminus. Assays can be helpful in the first screening of structurally significant and possibly phosphorylated residues in the N-terminus of GlyT2.

References

Tiwari P, Kaila P, Guptasarma P . Understanding anomalous mobility of proteins on SDS-PAGE with special reference to the highly acidic extracellular domains of human E- and N-cadherins. Electrophoresis. 2019; 40(9):1273-1281. DOI: 10.1002/elps.201800219. View

Jursky F, Baliova M . Expression and purification of recombinant calpain-derived N-terminal peptides from glycine transporter GlyT2. Protein Expr Purif. 2013; 88(1):143-9. DOI: 10.1016/j.pep.2012.12.007. View

Kelley L, Mezulis S, Yates C, Wass M, Sternberg M . The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015; 10(6):845-58. PMC: 5298202. DOI: 10.1038/nprot.2015.053. View

Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilagyi A, Banoczi Z . On the sequential determinants of calpain cleavage. J Biol Chem. 2004; 279(20):20775-85. DOI: 10.1074/jbc.M313873200. View

Tachida Y, Hirayama H, Suzuki T . Amino acid editing of NFE2L1 by PNGase causes abnormal mobility on SDS-PAGE. Biochim Biophys Acta Gen Subj. 2023; 1867(12):130494. DOI: 10.1016/j.bbagen.2023.130494. View

Baliova M, Betz H, Jursky F . Calpain-mediated proteolytic cleavage of the neuronal glycine transporter, GlyT2. J Neurochem. 2003; 88(1):227-32. DOI: 10.1046/j.1471-4159.2003.02192.x. View

Zafra F, Aragon C, Olivares L, Danbolt N, Gimenez C, Storm-Mathisen J . Glycine transporters are differentially expressed among CNS cells. J Neurosci. 1995; 15(5 Pt 2):3952-69. PMC: 6578198. View

Forsburg S, Sherman D . General purpose tagging vectors for fission yeast. Gene. 1997; 191(2):191-5. DOI: 10.1016/s0378-1119(97)00058-9. View

Marshall T, Williams K . Coomassie blue protein dye-binding assays measure formation of an insoluble protein-dye complex. Anal Biochem. 1992; 204(1):107-9. DOI: 10.1016/0003-2697(92)90147-y. View

10.

Baliova M, Jursky F . Phosphorylation of Serine 157 Protects the Rat Glycine Transporter GlyT2 from Calpain Cleavage. J Mol Neurosci. 2020; 70(8):1216-1224. DOI: 10.1007/s12031-020-01529-4. View

11.

Panayotatos N, Radziejewska E, Acheson A, Pearsall D, Thadani A, Wong V . Exchange of a single amino acid interconverts the specific activity and gel mobility of human and rat ciliary neurotrophic factors. J Biol Chem. 1993; 268(25):19000-3. View

12.

Varshavsky A . N-degron and C-degron pathways of protein degradation. Proc Natl Acad Sci U S A. 2019; 116(2):358-366. PMC: 6329975. DOI: 10.1073/pnas.1816596116. View

13.

Elce J, Hegadorn C, Gauthier S, Vince J, Davies P . Recombinant calpain II: improved expression systems and production of a C105A active-site mutant for crystallography. Protein Eng. 1995; 8(8):843-8. DOI: 10.1093/protein/8.8.843. View

14.

Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter D . Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron. 2003; 40(4):797-806. DOI: 10.1016/s0896-6273(03)00673-1. View

15.

Bi R, Bi X, Baudry M . Phosphorylation regulates calpain-mediated truncation of glutamate ionotropic receptors. Brain Res. 1998; 797(1):154-8. DOI: 10.1016/s0006-8993(98)00433-8. View

16.

Jahodova I, Baliova M, Jursky F . PDZ interaction of the GABA transporter GAT1 with the syntenin-1 in Neuro-2a cells. Neurochem Int. 2023; 165:105522. DOI: 10.1016/j.neuint.2023.105522. View

17.

Liu Q, Lopez-Corcuera B, Mandiyan S, Nelson H, Nelson N . Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features. J Biol Chem. 1993; 268(30):22802-8. View

18.

Jursky F, Nelson N . Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor. J Neurochem. 1995; 64(3):1026-33. DOI: 10.1046/j.1471-4159.1995.64031026.x. View

19.

Lawrence A, Besir H . Staining of proteins in gels with Coomassie G-250 without organic solvent and acetic acid. J Vis Exp. 2009; (30). PMC: 3149912. DOI: 10.3791/1350. View

20.

Yu T, Lee J, Yoon J, Choi J, Kim D, Heo W . Engineering of a Fluorescent Protein for a Sensing of an Intrinsically Disordered Protein through Transition in the Chromophore State. JACS Au. 2023; 3(11):3055-3065. PMC: 10685427. DOI: 10.1021/jacsau.3c00445. View